X
17Aug

UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?

Dechert LLP | | Return|
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/

Related

The RFP Process has to be on the up and up

Years ago, as a naïve associate at a semi-prestigious law firm (sorry Lois), I got the short end of ...

Read More >

Private Investment Funds Not Liable for Portfolio Company's Pension Withdrawal Liability

The U.S. Court of Appeals for the First Circuit has held in Sun Capital Partners III, LP v. New Engl...

Read More >

Risky "Business": A Refresher on Permissible (and not so permissible) Activities in B-1 Business Visitor Classification

Have you ever had any foreign nationals “visit” your company from one of your entities outside the...

Read More >

Risks from Abroad: COVID-19 Pandemic Slows Down CFIUS Review of Foreign Mergers and Acquisitions

The coronavirus outbreak has hindered many operations of the federal government, including the US re...

Read More >

Romanian government details UK citizens’ residence, employment and travel rights in case of a no-deal Brexit

Romanian government details UK citizens’ residence, employment and travel rights in case of a no-de...

Read More >

Portland Exempts Construction Companies and Contractors From City’s 1% Gross Receipts Tax

Since January 1, 2019, Portland has imposed a 1% gross receipts surcharge tax on “large retailers.”...

Read More >